BullFrog AI Holdings (BFRGW) Shares Outstanding (2021 - 2026)
BullFrog AI Holdings' (BFRGW) quarterly Shares Outstanding (Entity) came in at $18.5 million in Q2 2026, up 92.6% on a YoY basis from $9.6 million in Q2 2025, and up 62.39% quarter-over-quarter from $11.4 million in Q4 2025.
Analysis
BullFrog AI Holdings (BFRGW) Shares Outstanding (2021 - 2026) Analysis & Trends
BullFrog AI Holdings (BFRGW) has reported Shares Outstanding (Entity) for 6 consecutive years, with $18.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 92.6% year-over-year to $18.5 million; the trailing twelve-month figure through Jun 2026 stood at $18.5 million (up 92.6% YoY), and the FY2025 full-year result was $11.4 million, up 25.29% from the prior year.
- Shares Outstanding (Entity) grew to $18.5 million in Q2 2026 per BFRGW's latest filing, from $11.4 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $18.5 million in Q2 2026 and bottomed at $4.0 million in Q4 2022.
- Historically, Shares Outstanding (Entity) has averaged $7.9 million across 5 years, with a median of $7.9 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) slipped 13.0% in 2022, then soared 92.6% in 2026.
- Over 5 years, Shares Outstanding (Entity) stood at $4.0 million in 2022, then soared by 51.54% to $6.1 million in 2023, then surged by 49.53% to $9.1 million in 2024, then increased by 25.29% to $11.4 million in 2025, then surged by 62.39% to $18.5 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $18.5 million, $11.4 million, and $10.4 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.63 Bn | 197.64 Bn | 7.24 Bn | 540.00 Mn |
| 2 | Gilead Sciences | 181.39 Bn | 178.21 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 132.32 Bn | 124.47 Bn | 2.84 Bn | 253.70 Mn |
| 4 | Regeneron Pharmaceuticals | 82.47 Bn | 74.47 Bn | 3.93 Bn | 102.80 Mn |
| 5 | Argenx Se | 61.52 Bn | 56.34 Bn | 1.37 Bn | 61.30 Mn |
| 6 | Moderna | 54.79 Bn | 49.65 Bn | 52.00 Mn | 398.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.04 Bn | 30.73 Bn | 992.69 Mn | 133.61 Mn |
| 8 | Biogen | 31.39 Bn | 30.11 Bn | 1.96 Bn | 147.70 Mn |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn | 720.78 Mn |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 | 18.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.81 Mn |
| Dec 31, 2025 | 10.34 Mn |
| Sep 30, 2025 | 10.38 Mn |
| Jun 30, 2025 | 9.71 Mn |
| Mar 31, 2025 | 9.69 Mn |
| Dec 31, 2024 | 8.25 Mn |
| Sep 30, 2024 | 8.12 Mn |
| Jun 30, 2024 | 8.12 Mn |
| Mar 31, 2024 | 7.39 Mn |
| Dec 31, 2023 | 6.05 Mn |
| Sep 30, 2023 | 6.09 Mn |
| Jun 30, 2023 | 6.06 Mn |
| Mar 31, 2023 | 4.84 Mn |
| Dec 31, 2022 | 4.01 Mn |
| Sep 30, 2022 | 4.75 Mn |
| Jun 30, 2022 | 4.63 Mn |
| Mar 31, 2022 | 4.62 Mn |
| Dec 31, 2021 | 4.12 Mn |